Dr. Lokhorst - ASH 2008 - Final Analysis of HOVON-50 Randomized Phase III Study on the Effect of Thalidomide Combined with Adriamycine, Dexamethasone (AD) and High Dose Melphalan (HDM) in Patients with Multiple Myeloma (MM)
Henk M. Lokhorst, MD University Medical Center Utrecht Utrecht, Netherlands Member, IMF Board of Scientific Advisors
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.